DDX60L and familial pancreatic carcinoma: In this study, we found a novel potential oncogene – DDX60L. To validate the potential functions of DDX60L in pancreatic cancer (MYEOV was used as positive control), we designed three siRNAs to knockdown its expression in cancer cells (sequences are shown in Supplementary Table S1B).